GRIN2B and cancer: This pre-clinical study identified a novel pain cascade involving the release of IL-1β from a cancer-inoculated region, induction of ephrin B1 gene expression in DRGs, and subsequent enhancement of tyrosine phosphorylation of NR2B in the spinal cord.